The OS, failure-free survival and distant failure free survival rate was lower in nasopharyngeal carcinoma (NPC) patients and NPC patients with high tumor CTLA-4 levels [29]. This evidence concerns the gene CTLA4 and nasopharyngeal carcinoma.